SCHEMBL4393955

SCHEMBL4393955

CCc1c(O)cc(O)c(-c2ccccc2)c1Cc1ocnc1C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 12/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
CNR2 P34972 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ERCC1 P07992 1/20 0.36
FEN1 P39748 1/20 0.36
ERCC4 Q92889 1/20 0.36
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
FBP1 P09467 1/20 0.35
HSP90AA1 P07900 1/20 0.35
CYP2C9 P11712 1/20 0.35
PTGER4 P35408 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381492 0.82 PTGIR (0.36) PTGIRL3MBTL1SMN1; SMN2KDM4EALDH1A1
SCHEMBL4392464 0.81 GCGR (0.37) CNR2SMN1; SMN2MAPTCYP2C9
SCHEMBL4379839 0.80 ADORA2A (0.35) PTGIRCNR2SMN1; SMN2FBP1
SCHEMBL4379007 0.78 ADORA2A (0.44) PTGIRCNR2SMN1; SMN2FBP1
SCHEMBL4379268 0.75 PTGIR (0.42) PTGIRSMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL4384125 0.75 PTGIR (0.39) PTGIRHSP90AA1CYP2C9PTGER4PTGER2
SCHEMBL11317135 0.74 PTGIR (0.48) PTGIRSMN1; SMN2CYP2C9PTGER4PTGER2
SCHEMBL4388328 0.74 GCGR (0.39) CNR2SMN1; SMN2MAPTCYP2C9
SCHEMBL4392482 0.73 PTGIR (0.36) PTGIRL3MBTL1
SCHEMBL4387719 0.73 L3MBTL1 (0.35) PTGIRL3MBTL1SMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P PTGIR 2990/4885L3MBTL1 3218/4885CNR2 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.